Y-Intercept (HK)’s Ventyx Biosciences VTYX Stock Holding History

Y-Intercept (HK)’s Portfolio VTYX Stock Details VTYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-69,236	Closed	-$148K	–	2097
2025 Q2	$148K	Buy	+69,236	New	+$112K	﹤0.01%	1499

Other funds holding VTYX

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Y-Intercept (HK)'s VTYX Position: Q3 2025 in Review

Y-Intercept (HK) sold out of Ventyx Biosciences (VTYX) in Q3 2025, closing a stake of 69,236 shares — an estimated $148K sold.

Y-Intercept (HK) first reported a position in VTYX in Q2 2025 and held it in 1 quarter. The position peaked at $148K in Q2 2025. 110 funds tracked by Wall St. Rank hold VTYX as of Q3 2025.

Y-Intercept (HK) reported no remaining Ventyx Biosciences position as of Q3 2025 after selling out during the quarter.
Y-Intercept (HK) sold 69,236 Ventyx Biosciences shares in Q3 2025, an estimated $148K.
Y-Intercept (HK) first reported a position in Ventyx Biosciences in Q2 2025 and held it in 1 quarter.
Y-Intercept (HK)'s Ventyx Biosciences position peaked at $148K in Q2 2025.
110 funds tracked by Wall St. Rank held Ventyx Biosciences as of Q3 2025.

Based on Y-Intercept (HK)'s 13F filing for Q3 2025, filed 31 Oct 2025.